Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05951101

Zenith LAA Occlusion System

Evaluation of the Safety and Performance of the Zenith LAA Occlusion System and Procedure for the Mechanical Closure of the Left Atrial Appendage (LAA)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
AuriGen Medical Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Demonstrate the safety and performance of the Zenith LAA Occlusion System and procedure to occlude the Left Atrial Appendage (LAA) from the left atrium (LA) using a minimally invasive technique. Indication - LAA closure in patients with non-valvular atrial fibrillation, with an ostial diameter between 18 mm and 26 mm

Detailed description

The study objective is to demonstrate the safety and performance of the Zenith LAA Occlusion System and procedure to occlude the Left Atrial Appendage (LAA) from the left atrium (LA) using a minimally invasive technique.

Conditions

Interventions

TypeNameDescription
DEVICEZenith LAA Occlusion SystemLAA closure in patients with non-valvular atrial fibrillation, with an ostial diameter between 17 mm and 25 mm

Timeline

Start date
2024-03-28
Primary completion
2025-01-31
Completion
2025-12-31
First posted
2023-07-18
Last updated
2024-10-16

Locations

3 sites across 2 countries: Australia, New Zealand

Source: ClinicalTrials.gov record NCT05951101. Inclusion in this directory is not an endorsement.